Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001567619-21-012339

Options or other derivatives

  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Woiwode Thomas Director 2021-06-17 Grant or award · Stock Option (Right to Buy) +15,000 15,000 D: show line 1 in the form
Loading xslF345X03/doc1.xml…